Ridgemont Equity Partners buys AOM
By HME News Staff
Updated 9:35 AM CST, Tue March 1, 2022
CHARLOTTE, N.C. – Ridgemont Equity Partners, a buyout and growth equity investor, has acquired American Outcomes Management, a specialty infusion provider focused on intravenous immunoglobulin (IVIG) therapy. AOM provides home-based IVIG therapy to patients with more than 80 different chronic conditions. “Specialty infusion services have been a focus area for Ridgemont for many years,” said Petri Lindberg, Principal at Ridgemont. “It is a very large and growing market, driven by an aging population suffering from chronic conditions, a significant pipeline of specialty infusion drugs and increased adoption of at-home treatment. AOM is a scaled platform with a strong market position, best-in-class reputation in multiple key metro areas and dedicated focus on high quality infusion services. We are excited to partner with Chris York, a seasoned executive with decades of experience in the home infusion sector and longtime operating advisor to Ridgemont.” AOM also provides support services, including pharmacy services, referral management, insurance verification and patient education and training. The company holds pharmacy licenses in all 50 states.
Comments